iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

KIMS: Ramping-up Oncology and M&C specialty

21 Mar 2024 , 05:48 PM

Analysts of IIFL Securities hosted KIMS at IIFL’s Investor Conference in Mumbai. KIMS is focusing to ramp-up Oncology and Mother & Child specialty across its hospitals which should enable it to improve the case mix in AP, thereby leading to improvement in ARPOBs as well as reducing the dependency on other specialties by hiring new clinical talent. KIMS remains committed to set up Thane Hospital and will fund the asset itself if the deal is further delayed by end-Feb’24. KIMS remains on track to add 25% incremental bed capacities (1,000 beds) in FY25 across Nashik, Thane and Bangalore. These capacity expansions, along with double digit revenue Cagr in TG/AP hospitals and further margin improvement in Sunshine/Nagpur hospitals, should drive 18/21% overall revenue/Ebitda Cagr over the next 3 years. 

Ramping-up Oncology and Mother & Child specialty: 

With increased awareness and increase in the population of 40+ age group, Oncology segment has a huge potential in India and mgmt is preparing itself to capture this opportunity. The company has ordered 18 LINAC equipment for its 14 hospitals and have negotiated & fixed the price at Rs180mn per equipment (vs market rate of Rs250mn) which will be delivered over the next 24-48 months. KIMS M&C revenue contribution is 9% vs 6% three years ago and mgmt expects to increase its contribution to 15% over the next 2 years. KIMS being an adult multi-specialty hospital, will dedicate one floor/area for M&C under Cuddles brand. 

KIMS is committed to set up Thane hospital: 

The ground work is ongoing at Thane hospital and the only part that is pending is investor’s funding which KIMS expects to be completed by end-Feb or else the company will fund the project on its own. The total cost of the Hospital is Rs5.15bn, out of which Rs1.15bn will be borne by KIMS which is related to medical equipment and the balance Rs4bn will be borne by the investor. The deal is structured in such a way that KIMS can buy Thane asset after 7 years and giving an exit to the investor. Mgmt believes that the payback period of Thane hospital is going to be 8-8.5 years with RoCE of 18%. 

25% bed capacities to be added in FY25, through commissioning of the Nashik hospital (300 beds) in May’24, Thane (300)/Bangalore (415) hospitals in Q4FY25. KIMS expects doctors from smaller practices/organised competition to join them in Nashik. Mgmt is hopeful that Nashik hospital will achieve Ebitda breakeven within 12 months.

Related Tags

  • KIMS
sidebar mobile


Read More
Knowledge Centerplus

Logo IIFL Customer Care Number
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

Knowledge Centerplus

Follow us on


2024, IIFL Securities Ltd. All Rights Reserved

  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.